Allograft rejection after lung transplantation

Clinics in Chest Medicine

Volumn 26, Issue 4, 2005, Pages 599-612

  Whelan, Timothy P M ^a   Hertz, Marshall I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; DILTIAZEM; MACROLIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PHENOBARBITAL; PHENYTOIN; RAPAMYCIN; RIFAMPICIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ANAPHYLAXIS; ARTHRALGIA; ARTICLE; BACKACHE; BRONCHIOLITIS OBLITERANS; CATARACT; CHILL; CLINICAL FEATURE; DIABETES MELLITUS; DIARRHEA; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DYSPNEA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; GRAFT REJECTION; HEADACHE; HIRSUTISM; HUMAN; HYPERACUTE GRAFT REJECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INSOMNIA; LEUKOPENIA; LIVER TOXICITY; LUNG EDEMA; LUNG TRANSPLANTATION; MOOD DISORDER; MYOPATHY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OSTEOPOROSIS; PANCREATITIS; PERIPHERAL EDEMA; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; RIGOR; RISK ASSESSMENT; SERUM SICKNESS; SURVIVAL RATE; THORAX PAIN; THROMBOCYTOPENIA; TREMOR; VOMITING; WHEEZING; WOUND HEALING IMPAIRMENT;

EID: 27644594331     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.06.008     Document Type: Review

References (111)

1. J.D. Hardy, W.R. Webb, and M.L. Dalton Jr Lung homotransplantation in man JAMA 186 1963 1065 1074
2. C.R. Wildevuur, and J.R. Benfield A review of 23 human lung transplantations by 20 surgeons Ann Thorac Surg 9 1970 489 515
3. F.J. Veith Lung transplantation Surg Clin North Am 58 1978 357 364
4. F. Derom, F. Barbier, and S. Ringoir Ten-month survival after lung homotransplantation in man J Thorac Cardiovasc Surg 61 1971 835 846
5. Unilateral lung transplantation for pulmonary fibrosis. Toronto Lung Transplant Group N Engl J Med 314 1986 1140 1145
6. E.P. Trulock, L.B. Edwards, and D.O. Taylor The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004 J Heart Lung Transplant 23 2004 804 815
7. G.M. Williams, D.M. Hume, and R.P. Hudson Jr "Hyperacute" renal-homograft rejection in man N Engl J Med 279 1968 611 618
8. F. Kissmeyer-Nielsen, S. Olsen, and V.P. Petersen Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells Lancet 2 1966 662 665
9. A.E. Frost, C.T. Jammal, and P.T. Cagle Hyperacute rejection following lung transplantation Chest 110 1996 559 562
10. J.K. Choi, J. Kearns, and H.I. Palevsky Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings Am J Respir Crit Care Med 160 1999 1015 1018
11. H.B. Bittner, J. Dunitz, and M. Hertz Hyperacute rejection in single lung transplantation-case report of successful management by means of plasmapheresis and antithymocyte globulin treatment Transplantation 71 2001 649 651
12. J.C. Scornik, D.S. Zander, and M.A. Baz Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry Transplantation 68 1999 1542 1546
13. N.L. Reinsmoen, K. Nelson, and A. Zeevi Anti-HLA antibody analysis and crossmatching in heart and lung transplantation Transpl Immunol 13 2004 63 71
14. N.J. Rogers, and R.I. Lechler Allorecognition Am J Transplant 1 2001 97 102
15. M.D. Denton, C.C. Magee, and M.H. Sayegh Immunosuppressive strategies in transplantation Lancet 353 1999 1083 1091
16. P.M. Hopkins, C.L. Aboyoun, and P.N. Chhajed Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients J Heart Lung Transplant 21 2002 1062 1067
17. A. Zuckermann, H. Reichenspurner, and T. Birsan Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial J Thorac Cardiovasc Surg 125 2003 891 900
18. K. Bando, I.L. Paradis, and S. Similo Obliterative bronchiolitis after lung and heart-lung transplantation. an analysis of risk factors and management J Thorac Cardiovasc Surg 110 1995 4 13 [discussion: 13-4]
19. B. Whitehead, P. Rees, and K. Sorensen Incidence of obliterative bronchiolitis after heart-lung transplantation in children J Heart Lung Transplant 12 1993 903 908
20. R.E. Girgis, I. Tu, and G.J. Berry Risk factors for the development of obliterative bronchiolitis after lung transplantation J Heart Lung Transplant 15 1996 1200 1208
21. J.P. Scott, T.W. Higenbottam, and L. Sharples Risk factors for obliterative bronchiolitis in heart-lung transplant recipients Transplantation 51 1991 813 817
22. L.D. Sharples, M. Tamm, and K. McNeil Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation-early risk factors Transplantation 61 1996 560 566
23. A.N. Husain, M.T. Siddiqui, and E.W. Holmes Analysis of risk factors for the development of bronchiolitis obliterans syndrome Am J Respir Crit Care Med 159 1999 829 833
24. T.J. Kroshus, V.R. Kshettry, and K. Savik Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation J Thorac Cardiovasc Surg 114 1997 195 202
25. P.F. Halloran Immunosuppressive drugs for kidney transplantation N Engl J Med 351 2004 2715 2729
26. B.F. Meyers, J. Lynch, and E.P. Trulock Lung transplantation: a decade of experience Ann Surg 230 1999 362 370 [discussion 370-1]
27. S.M. Palmer, A.P. Miralles, and C.M. Lawrence Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study Chest 116 1999 127 133
28. M.V. Brock, M.C. Borja, and L. Ferber Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab J Heart Lung Transplant 20 2001 1282 1290
29. S.M. Bhorade, A. Jordan, and J. Villanueva Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation Am J Transplant 3 2003 1570 1575
30. R.J. Keenan, H. Konishi, and A. Kawai Clinical trial of tacrolimus versus cyclosporine in lung transplantation Ann Thorac Surg 60 1995 580 584 [discussion: 584-5]
31. S.M. Palmer, M.A. Baz, and L. Sanders Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection Transplantation 71 2001 1772 1776
32. A.R. Glanville, P.A. Corris, and K.D. McNeil Mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation for the prevention of bronchiolitis obliterans syndrome (BOS): results of a 3 year international randomised trial J Heart Lung Transplant 22 2003 S207 Available from: http://www.sciencedirect.com/science/article/B6VSG-47T8W48-H3/2/ fa92ba8c68e2b73b3fd286aa1c68c642 Accessed February 1, 2005
33. C. Knoop, A. Haverich, and S. Fischer Immunosuppressive therapy after human lung transplantation Eur Respir J 23 2004 159 171
34. M. Cantarovich, J.G. Besner, and J.S. Barkun Two-hour cyclosporine level determination is the appropriate tool to monitor neoral therapy Clin Transplant 12 1998 243 249
35. G. Levy, E. Thervet, and J. Lake Consensus on Neoral C(2): Expert Review in Transplantation (CONCERT) Group. Patient management by neoral C(2) monitoring: an international consensus statement Transplantation 73 2002 S12 S18
36. J.M. Morton, C.L. Aboyoun, and M.A. Malouf Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation J Heart Lung Transplant 23 2004 1035 1039
37. M.A. Baz, D.T. Layish, and J.A. Govert Diagnostic yield of bronchoscopies after isolated lung transplantation Chest 110 1996 84 88
38. E.P. Trulock, N.A. Ettinger, and E.M. Brunt The role of transbronchial lung biopsy in the treatment of lung transplant recipients. an analysis of 200 consecutive procedures Chest 102 1992 1049 1054
39. B. Millet, T.W. Higenbottam, and C.D. Flower The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation Am Rev Respir Dis 140 1989 62 67
40. S. Kundu, S.J. Herman, and A. Larhs Correlation of chest radiographic findings with biopsy-proven acute lung rejection J Thorac Imaging 14 1999 178 184
41. B.A. Otulana, T. Higenbottam, and L. Ferrari The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation Chest 97 1990 353 357
42. A. Van Muylem, C. Melot, and M. Antoine Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation Thorax 52 1997 643 647
43. F.S. Becker, F.J. Martinez, and L.A. Brunsting Limitations of spirometry in detecting rejection after single-lung transplantation Am J Respir Crit Care Med 150 1994 159 166
44. B. Morlion, C. Knoop, and M. Paiva Internet-based home monitoring of pulmonary function after lung transplantation Am J Respir Crit Care Med 165 2002 694 697
45. R.A. Guilinger, I.L. Paradis, and J.H. Dauber The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients Am J Respir Crit Care Med 152 1995 2037 2043
46. H.D. Tazelaar, F.N. Nilsson, and M. Rinaldi The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection J Thorac Cardiovasc Surg 105 1993 674 678
47. E.P. Trulock, N.A. Ettinger, and E.M. Brunt The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures Chest 102 1992 1049 1054
48. A. De Hoyos, D. Chamberlain, and R. Schvartzman Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation Chest 103 1993 1813 1818
49. S.A. Yousem, G.J. Berry, and P.T. Cagle Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group J Heart Lung Transplant 15 1996 1 15
50. A. El-Gamel, E. Sim, and P. Hasleton Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation J Heart Lung Transplant 18 1999 828 837
51. S.A. Yousem Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients Hum Pathol 27 1996 269 273
52. R.K. Sibley, G.J. Berry, and H.D. Tazelaar The role of transbronchial biopsies in the management of lung transplant recipients J Heart Lung Transplant 12 1993 308 324
53. P.M. Hopkins, C.L. Aboyoun, and P.N. Chhajed Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis Am J Respir Crit Care Med 170 2004 1022 1026
54. M.I. Hertz, and R.M. Bolman University of Minnesota. Physicians Transplant Program, Fairview Health Services manual of lung transplant medical care 2nd edition 2001 Fairview Publications Minneapolis (MN)
55. S. Kesten, A. Maidenberg, and T. Winton Treatment of presumed and proven acute rejection following six months of lung transplant survival Am J Respir Crit Care Med 152 1995 1321 1324
56. L.D. Sharples, K. McNeil, and S. Stewart Risk factors for bronchiolitis obliterans: a systematic review of recent publications J Heart Lung Transplant 21 2002 271 281
57. P. Vitulo, T. Oggionni, and A. Cascina Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation J Heart Lung Transplant 21 2002 435 439
58. N.R. Horning, J.P. Lynch, and S.R. Sundaresan Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation J Heart Lung Transplant 17 1998 761 767
59. D.R. Onsager, C.C. Canver, and M.S. Jahania Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients J Heart Lung Transplant 18 1999 448 455
60. K. Sarahrudi, M. Estenne, and P. Corris International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection J Thorac Cardiovasc Surg 127 2004 1126 1132
61. B.C. Cahill, M.K. O'Rourke, and K.A. Strasburg Methotrexate for lung transplant recipients with steroid-resistant acute rejection J Heart Lung Transplant 15 1996 1130 1137
62. H. Shennib, G. Massard, and M. Reynaud Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation J Heart Lung Transplant 13 1994 514 519
63. V.G. Valentine, R.C. Robbins, and J.H. Wehner Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts Chest 109 1996 1184 1189
64. G. Andreu, A. Achkar, and J.P. Couetil Extracorporeal photochemotherapy treatment for acute lung rejection episode J Heart Lung Transplant 14 1995 793 796
65. J. Villanueva, S.M. Bhorade, and J.A. Robinson Extracorporeal photopheresis for the treatment of lung allograft rejection Ann Transplant 5 2000 44 47
66. R.J. Keenan, A. Iacono, and J.H. Dauber Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients J Thorac Cardiovasc Surg 113 1997 335 340 [discussion 340-1]
67. B.D. Reams, R.D. Davis, and J. Curl Treatment of refractory acute rejection in a lung transplant recipient with Campath 1H Transplantation 74 2002 903 904
68. C.M. Burke, J. Theodore, and K.D. Dawkins Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation Chest 86 1984 824 829
69. J.D. Cooper, M. Billingham, and T. Egan A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Yransplantation J Heart Lung Transplant 12 1993 713 716
70. M. Estenne, J.R. Maurer, and A. Boehler Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 2002 297 310
71. M. Estenne, A. Van Muylem, and C. Knoop Detection of obliterative bronchiolitis after lung transplantation by indexes of ventilation distribution Am J Respir Crit Care Med 162 2000 1047 1051
72. G.M. Patterson, S. Wilson, and J.L. Whang Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second J Heart Lung Transplant 15 1996 175 181
73. M. Reynaud-Gaubert, P. Thomas, and M. Badier Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings Am J Respir Crit Care Med 161 2000 1924 1929
74. S.M. Finkelstein, M. Snyder, and C.E. Stibbe Staging of bronchiolitis obliterans syndrome using home spirometry Chest 116 1999 120 126
75. S.D. Nathan, S.D. Barnett, and J. Wohlrab Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients J Heart Lung Transplant 22 2003 427 432
76. M. Estenne, and M.I. Hertz Bronchiolitis obliterans after human lung transplantation Am J Respir Crit Care Med 166 2002 440 444
77. M.A. Quantz, L.E. Bennett, and D.M. Meyer Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations J Heart Lung Transplant 19 2000 473 479
78. S. Sundaresan, T. Mohanakumar, and M.A. Smith HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome Transplantation 65 1998 648 653
79. D. Heng, L.D. Sharples, and K. McNeil Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors J Heart Lung Transplant 17 1998 1255 1263
80. A. Jaramillo, M.A. Smith, and D. Phelan Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation Transplantation 67 1999 1155 1161
81. C.L. Lau, S.M. Palmer, and K.E. Posther Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients Ann Thorac Surg 69 2000 1520 1524
82. S.M. Palmer, R.D. Davis, and D. Hadjiliadis Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome Transplantation 74 2002 799 804
83. A.L. Girnita, R. Duquesnoy, and S.A. Yousem HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction Am J Transplant 5 2005 131 138
84. S.I. Reznik, A. Jaramillo, and L. Zhang Anti-HLA antibody binding to HLA class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome J Thorac Cardiovasc Surg 119 2000 39 45
85. G. Zissel, M. Ernst, and K. Rabe Human alveolar epithelial cells type II are capable of regulating T-cell activity J Investig Med 48 2000 66 75
86. C.A. Keller, P.T. Cagle, and R.W. Brown Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation Chest 107 1995 973 980
87. J.L. Billings, M.I. Hertz, and K. Savik Respiratory viruses and chronic rejection in lung transplant recipients J Heart Lung Transplant 21 2002 559 566
88. A.P. Khalifah, R.R. Hachem, and M.M. Chakinala Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death Am J Respir Crit Care Med 170 2004 181 187
89. J.D. Hosenpud, L.E. Bennett, and B.M. Keck The registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000 J Heart Lung Transplant 19 2000 909 931
90. S.M. Fiser, C.G. Tribble, and S.M. Long Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome Ann Thorac Surg 73 2002 1041 1047 [discussion 1047-8]
91. J. Feigelson, F. Girault, and Y. Pecau Gastro-oesophageal reflux and esophagitis in cystic fibrosis Acta Paediatr Scand 76 1987 989 990
92. R.W. Tobin, C.E. Pope II, and C.A. Pellegrini Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 158 1998 1804 1808
93. R.D. Davis Jr, C.L. Lau, and S. Eubanks Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation J Thorac Cardiovasc Surg 125 2003 533 542
94. E. Cantu III, J.Z. Appel III, and M.G. Hartwig Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease Ann Thorac Surg 78 2004 1142 1151 [discussion 1142-51]
95. G.M. Verleden, L.J. Dupont, and D. Van Raemdonck Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation J Heart Lung Transplant 22 2003 908 913
96. M. Dusmet, J. Maurer, and T. Winton Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients J Heart Lung Transplant 15 1996 948 954
97. G.M. Verleden, B. Buyse, and M. Delcroix Cyclophosphamide rescue therapy for chronic rejection after lung transplantation J Heart Lung Transplant 18 1999 1139 1142
98. A.J. Fisher, R.M. Rutherford, and J. Bozzino The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation Am J Transplant 5 2005 537 543
99. D.A. Diamond, J.M. Michalski, and J.P. Lynch Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation Int J Radiat Oncol Biol Phys 41 1998 795 800
100. G.I. Snell, D.S. Esmore, and T.J. Williams Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation Chest 109 1996 874 878
101. S. Kesten, N. Rajagopalan, and J. Maurer Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation Transplantation 61 1996 427 430
102. A.R. O'Hagan, P.C. Stillwell, and A. Arroliga Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation Chest 115 1999 1459 1462
103. C.T. Salerno, S.J. Park, and N.S. Kreykes Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis J Thorac Cardiovasc Surg 117 1999 1063 1069
104. B.A. Johnson, A.T. Iacono, and A. Zeevi Statin use is associated with improved function and survival of lung allografts Am J Respir Crit Care Med 167 2003 1271 1278
105. S.G. Gerhardt, J.F. McDyer, and R.E. Girgis Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study Am J Respir Crit Care Med 168 2003 121 125
106. G.M. Verleden, and L.J. Dupont Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation Transplantation 77 2004 1465 1467
107. H. Suzuki, Y. Asada, and K. Ikeda Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis Laryngoscope 109 1999 407 410
108. O. Culic, V. Erakovic, and I. Cepelak Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects Eur J Pharmacol 450 2002 277 289
109. K. Nagino, and H. Kobayashi Influence of macrolides on mucoid alginate biosynthetic enzyme from pseudomonas aeruginosa Clin Microbiol Infect 3 1997 432 439
110. T. Ichimiya, K. Takeoka, and K. Hiramatsu The influence of azithromycin on the biofilm formation of pseudomonas aeruginosa in vitro Chemotherapy 42 1996 186 191
111. T. Yamasaki, T. Ichimiya, and K. Hirai Effect of antimicrobial agents on the piliation of Pseudomonas aeruginosa and adherence to mouse tracheal epithelium J Chemother 9 1997 32 37